Therapeutic Effects and Molecular Mechanism of Chlorogenic Acid on Polycystic Ovarian Syndrome: Role of HIF-1alpha

Nutrients. 2023 Jun 21;15(13):2833. doi: 10.3390/nu15132833.

Abstract

Chlorogenic acid (CGA) is a powerful antioxidant polyphenol molecule found in many diets and liquid beverages, playing a preventive and therapeutic role in various diseases caused by oxidative stress and inflammation. Recent research has found that CGA can not only improve clinical symptoms in PCOS patients but also improve follicular development, hormone status, and oxidative stress in PCOS rats, indicating the therapeutic effect of CGA on PCOS. Notably, our previous series of studies has demonstrated the expression changes and regulatory mechanisms of HIF-1alpha signaling in PCOS ovaries. Considering the regulatory effect of CGA on the HIF-1alpha pathway, the present article systematically elucidates the therapeutic role and molecular mechanisms of HIF-1alpha signaling during the treatment of PCOS by CGA, including follicular development, steroid synthesis, inflammatory response, oxidative stress, and insulin resistance, in order to further understand the mechanisms of CGA effects in different types of diseases and to provide a theoretical basis for further promoting CGA-rich diets and beverages simultaneously.

Keywords: chlorogenic acid; follicular development; hormone synthesis; hypoxia inducible factor-1alpha; inflammatory response; oxidative stress; polycystic ovarian syndrome.

Publication types

  • Review

MeSH terms

  • Animals
  • Chlorogenic Acid / pharmacology
  • Chlorogenic Acid / therapeutic use
  • Female
  • Humans
  • Oxidative Stress
  • Polycystic Ovary Syndrome* / drug therapy
  • Polycystic Ovary Syndrome* / metabolism
  • Rats
  • Signal Transduction

Substances

  • Chlorogenic Acid